Company intelligence / Profile preview

Microbiome Health Sciences

Ownership: Private
Development stage: Clinical

Overview

Microbiome Health Sciences (operating as Microbiome Labs) develops clinically validated spore-based probiotic products aimed at restoring gut microbiota balance for whole-body wellness. Their solutions are used by thousands of healthcare practitioners. The company emphasizes scientific rigor in product development but does not appear to have traditional drug candidates in clinical trials; rather, their focus is on commercialized supplements with some clinical validation.

Therapeutic areas: GastroenterologyCardiovascularImmunologyWomen's Health
Modalities: ProbioticsPrebioticsDietary Supplements
Industry: Food & Nutrition

Partnerships

Thousands of healthcare practitioners use/distribute their products; specific major pharma/biotech partnerships not listed.

Beyond the preview

Go deeper on Microbiome Health Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiome Health Sciences.

Explore the full profile